$20M renewal of 4-decade-long federal grant to Hutch scientists
May 31, 2018
| By Susan Keown / Fred Hutch News Service
The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.
Former Fred Hutch, SCCA board chair was 'a rock of wisdom and stability' during pivotal times
Feb. 23, 2018
| By Mary Engel / Fred Hutch News Service
The former long-time member and chair of the Fred Hutch Board of Trustees, Shan Mullin was 'a rock of wisdom and stability' during pivotal times that included the founding of Seattle Cancer Care Alliance.
Physician-scientist led the charge in prioritizing fundamental research, built bridges between lab and clinic
Oct. 12, 2017
| By Rachel Tompa / Fred Hutch News Service
Dr. Paul Neiman, a founding member of Fred Hutchinson Cancer Research Center and a transplant physician and cancer biologist, died Oct. 11 of complications from pancreatic cancer. He was 78. Neiman was also one of the founders and leaders of the Basic Sciences Division, one of the Hutch’s five scientific divisions, as well as the division that would later became the Human Biology Division. He served as director of Basic Sciences from 1983 to 1995. He retired from Fred Hutch in 2010.
New research writes latest chapter in one drug's story
June 27, 2017
| by Susan Keown / Fred Hutch News Service
The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.